Neoplasms, Cystic, Mucinous, and Serous
Showing 1 - 25 of 2,513
Intraductal Papillary Mucinous Tumor of Pancreas Trial (Secretin, Endoscopic aspiration, Endoscopic ultrasound-guided fine
Not yet recruiting
- Intraductal Papillary Mucinous Neoplasm of Pancreas
- Secretin
- +2 more
- (no location specified)
Jun 12, 2023
Early Detection of Pancreatic Cystic Neoplasms
Recruiting
- Pancreatic Cysts
- +4 more
-
Baltimore, MarylandJohns Hopkins Hospital
Jul 7, 2022
Pancreatic Cyst, Pancreatic Tumors, Pancreatic Cancer Trial in San Francisco (Survey)
Recruiting
- Pancreatic Cyst
- +7 more
- Survey
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 20, 2022
True Exocrine Epithelial Pancreatic Cystic Neoplasms Based on
Completed
- Pancreas Cancer
- surgical resection
- (no location specified)
Apr 22, 2022
Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)
Not yet recruiting
- Endometrioid Cancer
- +3 more
- VS-6766 + defactinib
-
Oklahoma City, OklahomaStephenson Cancer Center
Aug 19, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Pancreatic Mucinous-Cystic Tumor Trial in United States (NanoPac®)
Completed
- Pancreatic Mucinous-Cystic Neoplasm
-
Fort Wayne, Indiana
- +3 more
Jun 7, 2021
Pancreatic Cystic Tumors Trial in Toronto (PET scan)
Completed
- Pancreatic Cystic Neoplasms
- PET scan
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 16, 2021
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic
Terminated
- Ovarian Cancer
- +21 more
- Exercise Counseling
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 6, 2022
Liquid Biopsies and Tumor Molecular Profiling in Predicting
Recruiting
- Endometrial Clear Cell Adenocarcinoma
- +5 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +32 more
- Carboplatin
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in
Not yet recruiting
- Stage I Testicular Seminoma
- +13 more
- Oncological Follow-up
-
Amiens, France
- +2 more
Aug 12, 2022
Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic
Recruiting
- Pancreatic Neoplasms
- +2 more
- cfDNA methylation sequencing and proteome analysis
-
Shanghai, Shanghai, ChinaChanghai Hospital
Feb 17, 2023
The Immune Landscape of Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Collection of tumor samples, blood and vaginal and rectal swabs
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland
Aug 2, 2023
Pancreatic Cyst, Serous Cystadenoma, Intraductal Papillary Mucinous Tumor Trial in Cambridge, London, Newcastle (AQ-Flex 19
Completed
- Pancreatic Cyst
- +3 more
- AQ-Flex 19 probe (Mauna Kea Technologies, Paris)
-
Cambridge, United Kingdom
- +3 more
Sep 30, 2019
Pancreatic Cyst, Pancreas Cyst, Serous Cystadenoma Trial in France (Molecular biology analysis of pancreatic intra-cyst fluid)
Active, not recruiting
- Pancreatic Cyst
- +4 more
- Molecular biology analysis of pancreatic intra-cyst fluid
-
Charenton-le-Pont, France
- +10 more
Apr 13, 2022
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
Pancreatic Cyst, Radiofrequency Ablation Trial in Columbus (EUS-guided radiofrequency ablation of pancreatic cyst, FDA-cleared
Recruiting
- Pancreatic Cyst
- Radiofrequency Ablation
- EUS-guided radiofrequency ablation of pancreatic cyst
- FDA-cleared device (EUS-RFA probe)
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Jun 14, 2023
Pancreatic Cyst Trial in Irvine, Aurora, New York (1). EUS-FNA plus MFB, 2). EUS-FNA Alone)
Recruiting
- Pancreatic Cyst
- 1). EUS-FNA plus MFB
- 2). EUS-FNA Alone
-
Irvine, California
- +2 more
Dec 8, 2021
PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS Trial (blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor
Not yet recruiting
- PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
- blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.
- (no location specified)
Aug 17, 2023
Microbial Diversity of Pancreatic Diseases
Recruiting
- Pancreatic Cancer
- Pancreatic Disease
-
Shanghai, Shanghai, ChinaRuijin Hospital
Dec 30, 2021
PCL With EUS-FNA and Cross-sectional Imaging - A Report of
Unknown status
- Pancreatic Cyst
- +7 more
- (no location specified)
Mar 19, 2019